期刊
CLINICAL CASES IN MINERAL AND BONE METABOLISM
卷 13, 期 2, 页码 131-134出版社
CIC EDIZIONI INT
DOI: 10.11138/ccmbm/2016.13.2.131
关键词
hyaluronic acid; osteoarthritis; injections
Osteoarthritis (OA) is a chronic degenerative joint disease characterized by pain and progressive functional limitation. Viscosupplementation with intra-articular (IA) hyaluronic acid (HA) could be a treatment option in OA, however recommendations made in different international guidelines for the non-surgical management of OA are not always concordant with regard to the role of IA injection therapies. Results from a recent Italian Consensus Conference underline how IA-HA to treat OA represents a widely used therapy in Italy. Specifically high molecular weight HA, crosslinked HA, and mobile reticulum HA are considered very useful to treat the OA joints from a great number of expert in Italy. These kinds of HA could reduce the NSAIDs intake, furthermore high-molecular weight and mobile reticulum HA are considered to be able to delay or avoid a joint prosthetic implant. This mini review highlights the results obtained from the Italian Consensus Conference Appropriateness of clinical and organizational criteria for intra-articular injection therapies in osteoarthritis and give further indication about innovation in IA-HA therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据